浙江東方(600120.SH)減持海康威視675.21萬股 套現3.18億元
格隆匯11月5日丨浙江東方(600120.SH)公佈,2020年10月28日-11月5日期間,公司通過二級市場累計減持了持有的海康威視(002415.SZ)股票675.2127萬股,佔海康威視總股本的0.0723%,減持後公司尚持有海康威視943.9273萬股,上述減持交易金額合計約3.18億元。
2019年1月1日起,公司執行新金融工具準則,將持有的海康威視股票資產分類為“以公允價值計量且其變動計入當期損益的金融資產”,預計該次處置股票資產對公司2020年度利潤總額的影響約為9604.29萬元(未考慮各項税金影響)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.